Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9544

Barium chloride dihydrate: Target Organs and Levels of Evidence for TR-432

Toxicology and Carcinogenesis Studies of Barium Chloride Dihydrate (CASRN 10326-27-9) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Barium chloride dihydrate
10326-27-9
Dosed-Water
0,125,4000 PPM/10 PER GROUP
SRI International

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Barium chloride dihydrate
10326-27-9
06/22/1993 Dosed-Water
0,500,1200,2500 PPM
T.S.I. Mason Laboratories, Inc.

Levels of Evidence

Male Rats: No Evidence
Type Organ/Tissue (Lesion)
Other Considerations
  • HEMATOPOIETIC SYSTEM: MONONUCLEAR CELL LEUKEMIA 35/50 25/50 26/50 15/50
  • ADRENAL GLAND: PHEOCHROMOCYTOMA 11/49 9/50 10/49 6/50 MALIGNANT PHEOCHROMOCYTOMA 2/49 2/50 2/49 0/50 COMBINED 13/49 11/50 12/49 6/50
Female Rats: No Evidence
Male Mice: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • KIDNEY: NEPHROPATHY
Other Considerations
  • LIVER: ADENOMA 24/51 20/50 15/48 8/50
Female Mice: No Evidence
Type Organ/Tissue (Lesion)
Non-Neoplastic Lesions
  • KIDNEY: NEPHROPATHY